Interleukin-2 Receptor Antagonist
DBCAT004302Pharmacologic class
A DrugBank category of 2 drugs. 2 of them are approved.
- Also known as
- Interleukin 2 Receptor Antagonists
What you can answer from here — as of October 03, 2019
Which targets do Interleukin-2 Receptor Antagonist share, and which companies have late-stage candidates in this class?
Create a free account or log in to explore the full data card.
Create Account